title: Effect of heparin on the production of matrix metalloproteinases and tissue inhibitors of metalloproteinases by human dermal fibroblasts.
abstract: The influence of heparin and a heparin fragment devoid of anticoagulant activity on the production of matrix metalloproteinases and tissue inhibitors of metalloproteinases by human dermal fibroblasts was studied. Doses (0.1-400 microg/ml) responses were performed and data obtained were similar whatever heparin or fragment was used. The basal expression of collagenase by fibroblasts decreased quasi-linearly with increasing doses of heparins from 1 to 400 microg/ml. TIMP-1 levels were not affected by supplementing serum free culture medium with heparins. On the contrary, at low concentration, i.e. 1-10 microg/ml, heparins stimulated the secretion of both 72-kDa gelatinase (1.4-1.6-fold) and particularly TIMP-2 (>4-fold). At high doses, MMP-2 and TIMP-2 production by fibroblasts returned to basal levels. These results suggested that the local concentration of heparin released by mast cells could be instrumental in modulating fibroblast growth and proteolytic phenotype.
authors.affiliation: Laboratory of Physiopathology of Non-Mineralized Tissues, University René Descartes Paris V, U.F.R. Odontology, 1 rue M. Arnoux, Montrouge, 92120, France.
authors.forename: B
authors.initials: B
authors.lastname: Gogly
authors.forename: M
authors.initials: M
authors.lastname: Dridi
authors.forename: W
authors.initials: W
authors.lastname: Hornebeck
authors.forename: M
authors.initials: M
authors.lastname: Bonnefoix
authors.forename: G
authors.initials: G
authors.lastname: Godeau
authors.forename: B
authors.initials: B
authors.lastname: Pellat
mesh_terms: D000293:Adolescent; D000328:Adult; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D005260:Female; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism*; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D020782:Matrix Metalloproteinases / Q000096:biosynthesis*; D012867:Skin / Q000187:drug effects / Q000378:metabolism; D019714:Tissue Inhibitor of Metalloproteinases / Q000096:biosynthesis*
chemical_list: D005343:Fibrinolytic Agents; D019714:Tissue Inhibitor of Metalloproteinases; D006493:Heparin; D020782:Matrix Metalloproteinases